Nucala (Mepolizumab)
Nucala is an injection that targets eosinophils, which are white blood cells that are a normal part of the body’s immune system. Too many eosinophils may lead to inflammation in your lungs. Inflammation can cause severe asthma attacks. Nucala is designed to reduce the number of eosinophils in your blood.
Indication:
Severe Eosinophilic Asthma
Add-on maintenance treatment of chronic rhinosinusitis with nasal Polyps in adults 18 years and older with inadequate response to nasal corticosteroids.
Eosinophilic Granulomatosis with Polyangiitis (Chur-Stauss Syndrome)
Hyper-eosinophilic Syndrome
Infusion Duration:
Frequency:
Every 4-weeks